InvestSMART

Dimerix Limited (ASX: DXB) - Announcements

Current share price for DXB : $0.285 0.005 (1.72%)+

ASX company news and announcements for Dimerix Limited (DXB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dimerix Limited (DXB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dimerix Limited (DXB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dimerix Limited (DXB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$171 Appendix 4G and Corporate Governance Statement 28 Aug 2025 9:29AM $0.475 $0.285 fallen by 40%
$171 Appendix 4E and 2025 Annual Report 28 Aug 2025 9:06AM $0.475 $0.285 fallen by 40%
$171 Investor Presentation and Recording 19 Aug 2025 8:57AM $0.460 $0.285 fallen by 38.04%
$171 Cleansing Notice 12 Aug 2025 3:08PM $0.480 $0.285 fallen by 40.63%
$171 Application for quotation of securities - DXB 12 Aug 2025 3:02PM $0.480 $0.285 fallen by 40.63%
$171 Dimerix presentation at Bioshares Biotech Summit 7 Aug 2025 9:05AM $0.490 $0.285 fallen by 41.84%
$171 Quarterly Appendix 4C and Activities Report 25 Jul 2025 8:35AM $0.550 $0.285 fallen by 48.18%
$171 Change of Director's Interest Notice - SP 7 Jul 2025 3:46PM $0.565 $0.285 fallen by 49.56%
$171 Application for quotation of securities - DXB 1 Jul 2025 12:23PM $0.580 $0.285 fallen by 50.86%
$171 Dimerix receives 1st Development Milestone payment from FUSO 30 Jun 2025 8:33AM $0.570 $0.285 fallen by 50%
$171 Application for quotation of securities - DXB 27 Jun 2025 3:22PM $0.580 $0.285 fallen by 50.86%
$171 Application for quotation of securities - DXB 24 Jun 2025 2:19PM $0.550 $0.285 fallen by 48.18%
$171 Change of Director's Interest Notice - SP 23 Jun 2025 1:27PM $0.555 $0.285 fallen by 48.65%
$171 Application for quotation of securities - DXB 19 Jun 2025 2:47PM $0.515 $0.285 fallen by 44.66%
$171 Investor Presentation 19 Jun 2025 8:21AM $0.500 $0.285 fallen by 43%
$171 Application for quotation of securities - DXB 17 Jun 2025 3:22PM $0.510 $0.285 fallen by 44.12%
$171 ACTION3 Clinical Trial Milestone Recruitment Update 13 Jun 2025 8:58AM $0.560 $0.285 fallen by 49.11%
$171 Application for quotation of securities - DXB 12 Jun 2025 12:02PM $0.550 $0.285 fallen by 48.18%
$171 Application for quotation of securities - DXB 10 Jun 2025 11:46AM $0.560 $0.285 fallen by 49.11%
$171 Application for quotation of securities - DXB 5 Jun 2025 3:47PM $0.568 $0.285 fallen by 49.78%
$171 Application for quotation of securities - DXB 3 Jun 2025 11:38AM $0.570 $0.285 fallen by 50%
$171 1st ACTION3 site in Japan activated and milestone triggered 30 May 2025 8:26AM $0.570 $0.285 fallen by 50%
$171 Application for quotation of securities - DXB 29 May 2025 1:28PM $0.570 $0.285 fallen by 50%
$171 Notification of upcoming expiry of Listed Options 29 May 2025 9:25AM $0.585 $0.285 fallen by 51.28%
$171 Application for quotation of securities - DXB 27 May 2025 2:02PM $0.610 $0.285 fallen by 53.28%

51 - 75 of 730 results

Page 3 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.